These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 15655144
1. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Lammert M, Friedman JM, Kluwe L, Mautner VF. Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144 [Abstract] [Full Text] [Related]
2. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Nunley KS, Gao F, Albers AC, Bayliss SJ, Gutmann DH. Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418 [Abstract] [Full Text] [Related]
3. [Neurofibromatosis in children. Our experience]. López-Pisón J, Cuadrado-Martín M, Boldova-Aguar MC, Muñoz-Mellado A, Cabrerizo de Diago R, Peña-Segura JL. Rev Neurol; 2009 Aug; 37(9):820-5. PubMed ID: 14606048 [Abstract] [Full Text] [Related]
4. [Managing children with neurofibromatosis type 1: what should we look for?]. Martins CL, Monteiro JP, Farias A, Fernandes R, Fonseca MJ. Acta Med Port; 2007 Aug; 20(5):393-400. PubMed ID: 18282435 [Abstract] [Full Text] [Related]
5. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature. Bernier A, Larbrisseau A, Perreault S. Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418 [Abstract] [Full Text] [Related]
8. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1? Yang CC, Happle R, Chao SC, Yu-Yun Lee J, Chen W. J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349 [Abstract] [Full Text] [Related]
9. [Pheochromocytoma associated with neurofibromatosis 1: a report of two cases]. Sano F, Fujikawa N, Hirai K, Ueki T, Kitami K. Hinyokika Kiyo; 2005 Dec; 51(12):793-5. PubMed ID: 16440725 [Abstract] [Full Text] [Related]
14. Genetic and clinical considerations in six cases with neurofibromatosis type 1. Buteică E, Stoicescu I, Burada F, Stănoiu B. Rom J Morphol Embryol; 2007 Jun 29; 48(3):243-8. PubMed ID: 17914490 [Abstract] [Full Text] [Related]
17. Epidemiology of neurofibromatosis type 1. Friedman JM. Am J Med Genet; 1999 Mar 26; 89(1):1-6. PubMed ID: 10469430 [Abstract] [Full Text] [Related]
18. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. Pasmant E, Sabbagh A, Hanna N, Masliah-Planchon J, Jolly E, Goussard P, Ballerini P, Cartault F, Barbarot S, Landman-Parker J, Soufir N, Parfait B, Vidaud M, Wolkenstein P, Vidaud D, France RN. J Med Genet; 2009 Jul 26; 46(7):425-30. PubMed ID: 19366998 [Abstract] [Full Text] [Related]
19. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Hyman SL, Shores A, North KN. Neurology; 2005 Oct 11; 65(7):1037-44. PubMed ID: 16217056 [Abstract] [Full Text] [Related]
20. Early grade repetition and inattention associated with neurofibromatosis type 1. Coudé FX, Mignot C, Lyonnet S, Munnich A. J Atten Disord; 2007 Sep 11; 11(2):101-5. PubMed ID: 17494836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]